Wall damage in simple ileus in rabbits: Immune-modulator role of somatostatin

Hepato-Gastroenterology

Volumn 51, Issue 58, 2004, Pages 1030-1036

  Jiménez García, Antonio ^a,b   Balongo García, Rafael ^a   Alconero, Francisco F ^a   Araji, Omar A ^a   Martínez, Gabriel J ^a   Haba, María G ^a   Morales, Luis C ^a   Beviá, José María O ^a   Martínez, José C ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b NONE   (Spain)

Author keywords

Interleukin 2; Interleukin 6; Intestinal obstruction; Serotonin; Somatostatin; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 6; SEROTONIN; SODIUM CHLORIDE; SOMATOSTATIN; TUMOR NECROSIS FACTOR ALPHA; HORMONE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 5; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; ILEUS; IMMUNOMODULATION; INTESTINE BIOPSY; INTESTINE OBSTRUCTION; INTESTINE PRESSURE; INTESTINE WALL; NONHUMAN; PRIORITY JOURNAL; SOMATOSTATIN BLOOD LEVEL; SPECIES COMPARISON; TISSUE SECTION; ANIMAL; CHEMISTRY; DRUG ADMINISTRATION; DRUG EFFECT; INTESTINE MUCOSA; JEJUNUM; METABOLISM; PATHOLOGY; RABBIT; STOMACH JUICE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL CONTENTS; HORMONES; ILEUS; INTERLEUKIN-2; INTERLEUKIN-5; INTESTINAL MUCOSA; JEJUNUM; LIPIDS; RABBITS; SEROTONIN; SOMATOSTATIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042515548     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barnett WO, Petro AB, Williamson JW: A current appraisal of problems with gangrenous bowel. Ann Surg 1978; 187:189-193.
2. Davis SE, Sperling L: Obstruction of the small intestine. Arch Surg 1969; 99:424-426.
3. Mucha P: Small intestinal obstruction. Surg Clin North Am 1987; 67:597-620.
4. Ohman U: Studies on small intestinal obstruction: blood flow, vascular resistance, capillary filtration, and oxygen consumption in denervated small bowel after obstruction. Acta Chir Scand 1975; 141:417-423.
5. Basson MD, Fielding LP, Bilchik AJ, Zucker KA, Ballantyne GH, Sussman J, Adrian T, Modlin DM: Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction? Am J Surg 1989; 157:109-115.
6. MacGregor IL, Lavigne ME: Inhibition by indomethacin of intestinal distension induced secretion in the rat. J Surg Res 1979; 26:167-170.
7. Morris D, Moore J, Crowe N: Serum tumor necrosis factor activity in horses with attributable to gastrointestinal tract disease. Am J Vet Res 1991; 52:1565-1569.
8. Reichlin S: Somatostatin. N Engl J Med 1983; 309:1495-1501.
9. Mulvihill SJ, Pappas TN, Fonkalsrud EW, Debas HT: The effect of somatostatin on experimental intestinal obstruction. Ann Surg 1988; 207:169-173.
10. Jimenez-Garcia A, Araji O, Balongo R, Nogales A, Salguero M, Cantillana J: Action de la somatostatine-14 dans l'occlusion mécanique simple de l'intestin grêle. J Chir (Paris) 1994; 131:104-110.
11. Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, Fiochi C: Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993; 104:794-758.
12. Podolsky DK: Peptide growth factors and regulation of growth in the intestine. In: Walsh JH, Dokray GJ (Eds.). Gut peptides: biochemistry and physiology. NY: Raven Press, 1994; pp. 803-823.
13. Yousefi S, Vaziri N, Carandang G, Le W, Yamamoto R, Granger G, Ocariz J, Cesario T: The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells. Br J Cancer 1991; 64:243-246.
14. Bermudez L, Young L: Effect of stress-related hormones on macrophage receptor and response to tumor necrosis factor. Lymphokine Res 1990; 9:137-145.
15. Furie MB, McHugh DD: Migration of nuetrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-α. J Immunol 1989; 134:3309-3317.
16. Reinecker H, Steffen M, Doehn C, Petersen J, Pfluger I, Voss A, Raedler A: Proinflammatory cytokines in intestinal mucosa. Immunol Res 1991; 10:247-248.
17. MacDonald T, Hutchings P, Choy M, Murch S, Cooke A: Tumor necrosis factor alpha and interferon gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990; 81:301-305.
18. Fink M: Gastrointestinal mucosa injury in experimental models of shock, trauma and sepsis. Crit Care Med 1991; 19:627-641.
19. Kandil HM, Berschneider HM, Argenzio RA: Tumour necrosis factor α changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut 1994; 35:934-940.
20. Nagi A, Babiuk L: Interleukin-2 production by mitogen-stimulated intestinal mucosa leukocytes from cattle. Am J Vet Res 1989; 50:1591-1597.
21. Hogan P, Gibson P, Hapel A, Doe W: Intestinal Lymphokine activated killer cells in inflammatory bowel disease. J Gastroenterol Hepatol 1991; 6:455-460.
22. Fais S, Annibale B, Boirivant M, Santoro A, Pallone F, Delle-fave G: Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activation. J Neuroimmunol 1991; 69:981-987.
23. McGee D, Beagley K, Aicher W, McGee J: Transforming growth factor beta enhances interleukin 6 secretion by intestinal epithelial cells. Immunology 1992; 77:7-12.
24. Wortel C, Derenter S, Aarden L, Lygidakis N, Büller r, Hoek F, Horikx J, Cate J: Interleukin 6 mediates host defense responses induced by abdominal surgery. Surgery 1993; 114:564-570.
25. Gorard DA, Libby GW, Farthing MJG: 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut 1994; 35:496-500.
26. Ottaway C: Neuroimmunomodulation in the intestinal mucosa. Gastroenterol Clin North Am 1991; 20:511-529.
27. Flageole h, Senterman M, Trudel J: Substance P increases in vitro lymphokine activated killer cell cytotoxicity against fresh colorectal cancer cells. J Surg Res 1992; 53:445-449.
28. Church M, El Lati S, Caulfield J: Neuropeptides induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 1991; 94:310-318.